The trials are the third phase of tests for MDMA-assisted psychotherapy for PTSD survivors, conducted by the Canadian arm of the Multidisciplinary Association for Psychedelic Studies, based in Santa Cruz, Calif.
MDMA, more commonly known as the party drug ecstasy, was shown to be upwards of 67 per cent effective in earlier phases of the clinical trials.
Executive director Mark Haden said results like those are remarkable, given that PTSD has been “relatively untreatable,” with most remedies being only 10-25-per-cent effective.
“PTSD is an unconscious tape-loop. It is an emotional response that somebody … will have in an repetitive way,” said Haden. “Their life is difficult to manage because the flashbacks are strong, intrusive and disturbing.”